CAS No. | Product Name | Molecular Formula |
---|---|---|
1019206-88-2 | Regorafenib monohydrate | C21H15ClF4N4O3.H2O |
102676-47-1 | Fadrozole | C14H13N3 |
110942-02-4 | 125-L-Serine-2-133-Interleukin 2(Human Reduced) | |
111490-36-9 | Zeniplatin | C11H22N2O6Pt |
121-00-6 | 4-Methoxy-6-tert-butylphenol | C11H16O2 |
1256963-02-6 | 4-(5-Chloro-3-isopropyl-1H-pyrazol-4-yl)-N-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine | C22H29ClN8 |
131374-93-1 | Lobaplatin | C9H18N2O3Pt |
148077-69-4 | 4-(4-Methylpiperazin-1-ylmethyl)benzoyl chloride | C13H17ClN2O |
150399-23-8 | Pemetrexed disodium | C20H19N5Na2O6 |
156436-89-4 | Xcytrin | C52H72GdN5O14++++ |
15663-27-1 | Cisplatin | Cl2H6N2Pt |
168555-66-6 | Combretastatin A4 disodium phosphate | C18H19Na2O8P |
170277-31-3 | Infliximab | |
174722-31-7 | Rituximab | C6416H9874N1688O1987S44 |
179324-69-7 | Bortezomib | C19H25BN4O4 |
191732-72-6 | Lenalidomide | C13H13N3O3 |
205923-56-4 | Cetuximab | C6484H10042N1732O2023S36 |
21416-87-5 | 4,4'-(1-Methyl-1,2-Ethanediyl)Bis-2,6-Piperazinedione | C11H16N4O4 |
2468-21-5 | Catharanthine | C21H24N2O2 |
288383-20-0 | Cediranib | C25H27FN4O3 |
331731-18-1 | Adalimumab | C6428H9912N1694O1987S46 |
339177-26-3 | Panitumumab | |
38390-45-3 | 3',4'-Anhydrovinblastine | C46H56N4O8 |
41575-94-4 | Carboplatin | C6H12N2O4Pt |
50264-69-2 | Lonidamine | C15H10Cl2N2O2 |
53-19-0 | Mitotan | C14H10Cl4 |
615258-40-7 | Denosumab | C6404H9912N1724O2004S50 |
61825-94-3 | Oxaliplatin | C8H12N2O4Pt |
63121-00-6 | Oxaliplatin | C6H14N2.C2O4.Pt |
74-93-1 | Methanethiol | CH4S |
78186-34-2 | Bisantrene | C22H22N8 |
815610-63-0 | Ustekinumab | |
918504-65-1 | Vemurafenib | C23H18ClF2N3O3S |
946414-94-4 | Nivolumab |